DMK

DMK Pharmaceuticals (DMK)

DMK Pharmaceuticals Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DMK

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/22	03:23	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/02/08	07:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/02/07	00:04	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/02/05	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/02/01	07:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/01/24	07:23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/01/24	07:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/01/04	07:03	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/01/04	07:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2024/01/04	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/12/22	02:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/12/21	22:15	GlobeNewswire Inc.	DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/12/05	06:47	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/12/05	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/29	06:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/28	22:05	GlobeNewswire Inc.	DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/16	06:39	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/16	06:20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/16	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/16	06:06	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/15	05:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/14	21:30	GlobeNewswire Inc.	DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/14	00:52	GlobeNewswire Inc.	DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/03	05:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/11/03	05:31	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/10/30	20:30	GlobeNewswire Inc.	DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/10/26	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/10/26	06:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/10/21	05:15	GlobeNewswire Inc.	DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:DMK	DMK Pharmaceuticals Corporation
2023/10/20	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMK	DMK Pharmaceuticals Corporation